melphalan and Giant-Cell-Tumors

melphalan has been researched along with Giant-Cell-Tumors* in 5 studies

Other Studies

5 other study(ies) available for melphalan and Giant-Cell-Tumors

ArticleYear
Isolated limb perfusion as a treatment option for rare types of tumours.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2016, Volume: 32, Issue:6

    Isolated limb perfusion (ILP) is an established and effective treatment for advanced melanoma and soft tissue sarcomas of the extremities with a high overall response rate. The aim of this study was to describe our experience of ILP for more rare types of tumours.. Patients with Merkel cell carcinoma (MCC) (n = 4), squamous cell carcinoma (SCC) (n = 2), B-cell lymphoma (n = 1), desmoid tumours (n = 3), pigmented villonodular synovitis (PVNS) (n = 1) and giant cell tumour (n = 1) were treated with ILP and analysed retrospectively.. The four patients with in-transit MCC had three complete responses (CR) and one partial response (PR); the two patients with SCC had one CR and one stable disease (SD); the patients with desmoid tumours had two PR and one SD. A CR was also observed for the patient with a giant cell tumour, but the patient with PVNS had a SD. The patient with cutaneous metastases of B-cell lymphoma showed a CR, however with rapid systemic progression. Local toxicity according to Wieberdink was grade II in 10 patients (83%) and grade III in two patients (17%).. These results show that ILP can be used as a treatment option also for more rare disease entities when other treatments have failed.

    Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Antineoplastic Agents, Alkylating; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Extremities; Fibromatosis, Aggressive; Giant Cell Tumors; Humans; Hyperthermia, Induced; Lymphoma, B-Cell; Melphalan; Perfusion; Rare Diseases; Synovitis, Pigmented Villonodular; Tumor Necrosis Factor-alpha

2016
[Functional state of the liver during radiation and drug therapy in malignant tumors of the bones].
    Meditsinskaia radiologiia, 1974, Volume: 19, Issue:7

    Topics: Bone Neoplasms; Cyclophosphamide; Giant Cell Tumors; Humans; Liver; Melphalan; Osteoma, Osteoid; Osteosarcoma; Radiation Effects; Radiotherapy; Radiotherapy Dosage; Sarcoma; Sarcoma, Ewing

1974
[Complex treatment of primary malignant bone neoplasms].
    Ortopediia travmatologiia i protezirovanie, 1971, Volume: 32, Issue:5

    Topics: Adolescent; Amputation, Surgical; Anti-Bacterial Agents; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Chondrosarcoma; Giant Cell Tumors; Hip; Humans; Lymphoma, Large B-Cell, Diffuse; Melphalan; Neoplasm Metastasis; Osteosarcoma; Radioisotopes; Sarcoma, Ewing; Shoulder; Vitamins

1971
[The results of treatment of maxillary sarcomas].
    Voprosy onkologii, 1970, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Child; Fibrosarcoma; Giant Cell Tumors; Hemangiosarcoma; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Maxillary Neoplasms; Melphalan; Middle Aged; Myxosarcoma; Osteosarcoma; Radioisotope Teletherapy; Sarcoma; Thiotepa

1970
POSTRADIATION SARCOMA ARISING IN GIANT CELL TUMOR OF BONE. REPORT OF A CASE.
    Chinese medical journal (Peking, China : 1932), 1964, Volume: 83

    Topics: Bone Neoplasms; Elbow; Giant Cell Tumor of Bone; Giant Cell Tumors; Melphalan; Neoplasms; Neoplasms, Radiation-Induced; Pathology; Radiography; Sarcoma

1964